Tarsus Pharmaceuticals, Inc. (TARS) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGS. Market cap 3.38B USD. 52-week range 53.89 to 91.53 USD. Data as of 2026-10-09.
Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company offers XDEMVY, a lotilaner ophthalmic solution for the treatment of demodex blepharitis caused by the infestation of Demodex mites. It sells its products to specialty pharmacies and distributors, as well as clinics, hospitals, pharmacies, and federal healthcare programs. The company also develops ...